Processa Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2014 to Q3 2024.
  • Processa Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -163 %, a 26.4% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Return On Assets for 2023 was -122 %, a 18.4% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Return On Assets for 2022 was -150 %, a 293% decline from 2021.
  • Processa Pharmaceuticals, Inc. annual Return On Assets for 2021 was -38.1 %, a 63.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -163 +58.5 +26.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -130 +76.2 +36.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -116 +68.2 +37% Jan 1, 2024 Mar 31, 2024
Q4 2023 -122 +27.7 +18.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -222 -144 -187% Jul 1, 2023 Sep 30, 2023
Q2 2023 -206 -149 -259% Apr 1, 2023 Jun 30, 2023
Q1 2023 -184 -139 -307% Jan 1, 2023 Mar 31, 2023
Q4 2022 -150 -112 -293% Oct 1, 2022 Dec 31, 2022
Q3 2022 -77.3 -16.7 -27.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -57.4 +15.4 +21.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.3 +34.8 +43.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -38.1 +67.1 +63.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -60.6 -6.71 -12.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -72.8 -41.7 -134% Apr 1, 2021 Jun 30, 2021
Q1 2021 -80 -47.7 -147% Jan 1, 2021 Mar 31, 2021
Q4 2020 -105 -75.4 -253% Oct 1, 2020 Dec 31, 2020
Q3 2020 -53.9 -26.5 -96.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -31.1 -5.31 -20.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -32.4 -6.3 -24.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -29.8 -1.52 -5.38% Oct 1, 2019 Dec 31, 2019
Q3 2019 -27.4 +7.28 +21% Jul 1, 2019 Sep 30, 2019
Q2 2019 -25.8 +22.2 +46.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -26.1 +42.2 +61.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -28.3 +214 +88.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -34.6 +203 +85.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -48 +214 +81.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -68.2 +237 +77.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -242 +65.7 +21.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -238 +3.31K +93.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -262 +612 +70% Apr 1, 2017 Jun 30, 2017
Q1 2017 -306 +477 +61% Jan 1, 2017 Mar 31, 2017
Q4 2016 -308 +25.7 +7.69% Oct 1, 2016 Dec 31, 2016
Q3 2016 -3.55K -3.27K -1167% Jul 1, 2016 Sep 30, 2016
Q2 2016 -873 -641 -275% Apr 1, 2016 Jun 30, 2016
Q1 2016 -783 -638 -439% Jan 1, 2016 Mar 31, 2016
Q4 2015 -333 -167 -101% Oct 1, 2015 Dec 31, 2015
Q3 2015 -280 -146 -109% Jul 1, 2015 Sep 30, 2015
Q2 2015 -233 -114 -95.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -145 -35.9 -32.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -166 Oct 1, 2014 Dec 31, 2014
Q3 2014 -134 Jul 1, 2014 Sep 30, 2014
Q2 2014 -119 Apr 1, 2014 Jun 30, 2014
Q1 2014 -109 Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.